Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-01-19
1996-08-13
Clardy, S. Mark
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514913, A61K 31735
Patent
active
055456260
ABSTRACT:
The present invention provides a method of treating glaucoma which comprises administering to a subject an effective amount of an oligonucleotide which may be substituted or modified in its phosphate, sugar, or base, so as to decrease intraocular pressure and thereby treat the glaucoma.
REFERENCES:
patent: 5320962 (1994-06-01), Stiles et al.
Crosson. Current Eye Research. 11 (5):453-458. "Ocular Hypotensive Activity of the Adenosine Agonist . . . " 1992.
Loke et al. Proc Nat'l Acad Sci. USA. 86:3474-3478. "Characterization of oligonucleotide transport into living cells." May 1989.
Bowman, E.J., et al. (1988) "Bafilomycins: A class of Inhibitors of Membrane ATPases from Microorganisms, Animal Cells, and Plant Cells", Proc. Natl. Acad. Sci. U.S.A. 85:7972-7976 (Exhibit 2).
Harvey, W. R. (1992) "Physiology of V-ATPases", J. Exp. Biol. 172:1-17 (Exhibit 3).
Iversen, P. (1991) "In Vivo Studies With Phosphorothioate Oligonucleotides: Pharmacokinetics Prologue", Anti-Cancer Drug Design 6:531-538 (Exhibit 4).
Mellman, I., et al. (1986) "Acidification of the Endocytic and Exocytic Pathways", Ann. Rev. Biochem 55:663-700 (Exhibit 5).
Morimaya, Y., and Nelson, N. (1988) "Inhibition of Vacuolar H.sup.+ -ATPases by Fusidic Acid and Suramin", FEBS Let. 234:383-386 (Exhibit 6).
Nelson, R. D. et al. (1992) "Selectively Amplified Expression of an Isoform of the Vacuolar H.sup.+ -ATPase 56-Kilodaton Subunit in Renal Intercalated Cells" Proc. Natl. Acad. Sci. U.S.A. 89:3541-3545 (Exhibit 7).
Stein, C. A., and Cheng, Y.--C. (Aug. 1993) "Antisense Oligonucleotides as Therapeutic Agents-Is the Bullet Really Magical?", Science 261:1004-1012 (Exhibit 8).
Uhlmann, E., and Peyman, A. (1990) "Antisense Oligonucleotides: A New Therapeutic Principle", Chemical Reviews 90:543-584 (Exhibit 9).
Wax, M. (1992) "Signal Transduction in the Ciliary Epithelium", Pharmocology of Glaucoma, Williams & Wilkins, Baltimore pp. 84-210 (Exhibit 10).
Yilla, M., et al. (Sep. 1993) "Involvement of the Vacuolar H.sup.+ -ATPases in the Secretory Pathway of HepG2 Cells", J. Biol. Chem. 268-19092-19100 (Exhibit 11).
Stein Cy A.
Wax Martin B.
Clardy S. Mark
The Trustees of Columbia University in the City of New York
Washington University
White John P.
LandOfFree
Method of treating glaucoma with oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating glaucoma with oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating glaucoma with oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1047987